p53 (TRP53) deficiency-mediated antiapoptosis escape after 5 Gy X irradiation still induces stem cell leukemia in C3H/He mice: Comparison between whole-body assay and bone marrow transplantation (BMT) assay

Radiation Research

Volumn 167, Issue 6, 2007, Pages 703-710

  Yoshida, Kazuko ^a   Hirabayashi, Yoko ^b   Wada, Sachiko ^a   Watanabe, Fumiko ^a   Watanabe, Keiko ^a   Aizawa, Shiro ^a   Inoue, Tohru ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; C3H MOUSE; CONTROLLED STUDY; HETEROZYGOTE; INCIDENCE; LEUKEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; X IRRADIATION; ANIMAL; APOPTOSIS; C57BL MOUSE; COMPARATIVE STUDY; GENETICS; METHODOLOGY; MOUSE MUTANT; PATHOPHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; STEM CELL; SURVIVAL; SURVIVAL RATE; TRANSGENIC MOUSE; WHOLE BODY RADIATION;

MUS;

ANIMALS; APOPTOSIS; BONE MARROW TRANSPLANTATION; LEUKEMIA, RADIATION-INDUCED; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RADIATION DOSAGE; STEM CELLS; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; WHOLE-BODY IRRADIATION;

EID: 34447527666     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0820.1     Document Type: Article

References (33)

1. Y. Hirabayashi and T. Inoue, Toxicogenomics applied to hematotoxicology. In Handbook of Toxicogenomics (J. Borlak, Ed.), pp. 583-608. Wiley-VCH, Verlag GmbH, Weinheim, 2005.
2. K. Yoshida, T. Inoue, K. Nojima, Y. Hirabayashi and T. Sado, Calorie restriction reduces the incidence of myeloid leukemia induced by a single whole-body radiation in C3H/He mice. Proc. Natl. Acad. Sci. USA 94, 2615-2619 (1997).
3. K. Yoshida, Y. Hirabayashi, F. Watanabe, T. Sado and T. Inoue, Calorie restriction prevents radiation-induced myeloid leukemia in C3H/HeMs mice and inversely increases incidence of tumor-free death: Implications in changes in number of hemopoietic progenitor cells. Exp. Hematol. 34, 274-283 (2006).
4. K. Yoshida, K. Nojima, M. Seki and T. Inoue, Radiation-induced myeloid leukemia following splenectomy in C3H/He mice. J. Radiat. Res. 37, 380 (1996).
5. W. C. Moloney and V. P. King, Reduction of leukemia incidence following splenectomy in the rat. Cancer Res. 33, 573-574 (1973).
6. P. K. Kalpaktsoglou, E. J. Yunis and R. A. Good, Early splenectomy and survival of inbred mice. Nature 215, 633-634 (1967).
7. I. R. Major and R. H. Mole, Myeloid leukaemia in X-ray irradiated CBA mice. Nature 272, 455-456 (1978).
8. M. Seki, K. Yoshida, M. Nishimura and K. Nemoto, Radiation-induced myeloid leukemia in C3H/He mice and the effect of prednisolone acetate on leukemogenesis. Radiat. Res. 127, 146-149 (1991).
9. K. Yoshida, S. Aizawa, K. Watanabe, Y. Hirabayashi and T. Inoue, Stem-cell leukemia: p53 deficiency mediated suppression of leukemic differentiation in C3H/He myeloid leukemia. Leuk. Res. 26, 1085-1092 (2002).
10. T. Jacks, L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson and R. A. Weinberg, Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7 (1994).
11. C. J. Kemp, T. Wheldon and A. Balmain, p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat. Genet. 8, 66-69 (1994).
12. L. A. Donehower, M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, Jr., J. S. Butel and A. Bradley, Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992).
13. D. Malkin, F. P. Li, L. C. Strong, J. F. Fraumeni, Jr., C. E. Nelson, D. H. Kim, J. Kassel, M. A. Gryka, F. Z. Bischoff and M. A. Tainsky, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233-1238 (1990).
14. S. Srivastava, Z. Q. Zou, K. Pirollo, W. Blattner and E. H. Chang, Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348, 747-749 (1990).
15. T. Tsukada, Y. Tomooka, S. Takai, Y. Ueda, S. Nishikawa, T. Yagi, T. Tokunaga, N. Takeda, Y. Suda and S. Aizawa, Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8, 3313-3322 (1993).
16. J. E. Till and E. A. McCulloch, A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213-222 (1961).
17. J. Lesley, R. Schulte and R. Hyman, Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp. Cell Res. 187, 224-233 (1990).
18. C. H. Frith, J. M. Ward, J. H. Harleman, P. C. Stromberg, S. Halm, T. Inoue and J. A. Wright, Hematopoietic system. In International Classification of Rodent Tumors: The Mouse (U. Mohr, Ed.), pp. 417-451. Springer-Verlag, Berlin and Heidelberg, 2001.
19. M. B. Kastan, A. I. Radin, S. J. Kuerbitz, O. Onyekwere, C. A. Wolkow, C. I. Civin, K. D. Stone, T. Woo, Y. Ravindranath and R. W. Craig, Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res. 51, 4279-4286 (1991).
20. E. Feinstein, R. P. Gale, J. Reed and E. Canaani, Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene 7, 1853-1857 (1992).
21. S. Soddu, G. Blandino, G. Citro, R. Scardigli, G. Piaggio, A. Ferber, B. Calabretta and A. Sacchi, Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood 83, 2230-2237 (1994).
22. T. Skorski, M. Nieborowska-Skorska, P. Wlodarski, D. Perrotti, R. Martinez, M. A. Wasik and B. Calabretta, Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 93, 13137-13142 (1996).
23. S. Venkatachalam, Y. P. Shi, S. N. Jones, H. Vogel, A. Bradley. D. Pinkel and L. A. Donehower, Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation. EMBO J. 17, 4657-4667 (1998).
24. I. Hayata, M. Seki, K. Yoshida, K. Hirashima, T. Sado, J. Yamagiwa and T. Ishihara, Chromosomal aberrations observed in 52 mouse myeloid leukemias. Cancer Res. 43, 367-373 (1983).
25. N. Ban, K. Yoshida, S. Aizawa, S. Wada and M. Kai, Cytogenetic analysis of radiation-induced leukemia in Trp53-deficient C3H/He mice. Radiat. Res. 158, 69-77 (2002).
26. S. J. Kuerbitz, B. S. Plunkett, W. V. Walsh and M. B. Kastan, Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89, 7491-7495 (1992).
27. W. J. Slichenmyer, W. G. Nelson, R. J. Slebos and M. B. Kastan, Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53, 4164-4168 (1993).
28. S. W. Lowe, E. M. Schmitt, S. W. Smith, B. A. Osborne and T. Jacks, p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849 (1993).
29. A. R. Clarke, S. Gledhill, M. L. Hooper, C. C. Bird and A. H. Wyllie, p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 9, 1767-1773 (1994).
30. A. J. Merritt, C. S. Potten, C. J. Kemp, J. A. Hickman, A. Bahnain, D. P. Lane and P. A. Hall, The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of norma, and p53-deficient mice. Cancer Res. 54, 614-617 (1994).
31. J. Lotem and L. Sachs, Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 82, 1092-1096 (1993).
32. Y. Hirabayashi, K. Yoshida, S. Aizawa, Y. Kodama, J. Kanno, Y. Kurokawa, I. Yoshimura and T. Inoue, Evaluation of nonthreshold leukemogenic response to methyl nitrosourea in p53-deficient C3H/He mice. Toxicol. Appl. Pharmacol. 190, 251-261 (2003).
33. M. A. Christophorou, I. Ringshausen, A. J. Finch, L. B. Swigart and G. I. Evan, The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443, 214-217 (2006).